mTOR通路:在糖尿病病进展和治疗点中的一个关键参与者
Jingxuan Shi1,2, Xinze Liu3, Yuanyuan Jiao4
1Department of Nephrology, China-Japan Friendship Hospital, Beijing 100029, China.
Genes & diseases
|December 24, 2024
概括
糖尿病病是一种主要的糖尿病并发症,缺乏有效的治疗方法. 针对mTOR途径显示出通过解决其在疾病进展中的作用来改善脏结果的希望.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 内分泌学 在内分泌学.
- 分子生物学分子生物学
背景情况:
- 糖尿病病是全球末期病的主要原因之一.
- 目前糖尿病病的治疗方法由于复杂的发病因而有限.
- 哺乳动物的拉巴胺素 (mTOR) 途径的标与糖尿病病进展有关.
研究的目的:
- 在关键的细胞和免疫细胞中审查糖尿病病症的病理机制.
- 巩固目前针对糖尿病脏病的mTOR向治疗方法的研究.
- 为新的治疗和预防策略提供理论基础.
主要方法:
- 在 podocytes, mesangial 细胞,管状上皮细胞,内皮细胞,巨细胞和T 淋巴细胞中的病理机制的文献综述.
- 分析mTOR途径在自抑制,炎症和氧化应激中的作用.
- 对针对mTOR信号通路的现有和新兴药物的调查.
主要成果:
- mTOR信号传递通过影响各种脏和免疫细胞中的细胞过程,导致糖尿病病.
- 自,炎症和氧化应激的失调是mTOR驱动的关键机制.
- 一些针对mTOR的药物和分子在临床前和临床研究中显示出潜力.
结论:
- 了解mTOR在糖尿病病发病的作用对于开发向疗法至关重要.
- 与mTOR通路的干扰为改善脏预后提供了一个有希望的治疗途径.
- 对mTOR抑制剂的进一步研究可能会导致糖尿病病的有效治疗和预防策略.
更多相关视频
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
82
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
468
相关概念视频
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
01:22PI3K/mTOR/AKT Signaling Pathway
3.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.3K
01:41Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
02:54Canonical Wnt Signaling Pathway
8.6K
The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
8.6K
01:15Diabetes: Management and Pharmacotherapy
203
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
203